Molecular Cancer apeutics linical Development one Deacetylase Inhibition Attenuates Cell Growth with ociated Telomerase Inhibition in High-Grade Ther ldhood Brain Tumor Cells

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations.

  2010cited by this paper
• Experimental study on inhibitory effects of histone deacetylase inhibitor MS-275 and TSA on bladder cancer cells.

  2010cited by this paper
• Pediatric phase I trial and pharmacokinetic study of vorinostat: a Children's Oncology Group phase I consortium report.

  2010cited by this paper
• HDACi--targets beyond chromatin.

  2009cited by this paper
• Epigenomic profiling of cancer cells.

  2009cited by this paper
• Antitumor effects of a combined 5-aza-2'deoxycytidine and valproic acid treatment on rhabdomyosarcoma and medulloblastoma in Ptch mutant mice.

  2009cited by this paper
• Phase II trial of vorinostat in recurrent glioblastoma multiforme: a north central cancer treatment group study.

  2009cited by this paper
• Development of vorinostat: current applications and future perspectives for cancer therapy.

  2009cited by this paper
• Childhood Brain Tumors: Accomplishments and Ongoing Challenges

  2008cited by this paper
• Telomerase and cancer therapeutics

  2008cited by this paper
• Histone deacetylase inhibitors enhance the chemosensitivity of tumor cells with cross‐resistance to a wide range of DNA‐damaging drugs

  2008cited by this paper
• Histone deacetylase inhibitors trichostatin A and valproic acid induce cell cycle arrest and p21 expression in immortalized human endometrial stromal cells.

  2008cited by this paper
• Multifactorial analysis of predictors of outcome in pediatric intracranial ependymoma.

  2008cited by this paper
• Inhibition of telomerase activity and human telomerase reverse transcriptase gene expression by histone deacetylase inhibitor in human brain cancer cells.

  2007cited by this paper
• Histone deacetylase inhibitors: molecular mechanisms of action

  2007cited by this paper
• Suberoylanilide Hydroxamic Acid, a Histone Deacetylase Inhibitor: Effects on Gene Expression and Growth of Glioma Cells In vitro and In vivo

  2007cited by this paper
• Histone Deacetylase Inhibitors: Overview and Perspectives

  2007cited by this paper
• Induction of apoptosis and inhibition of telomerase activity by trichostatin A, a histone deacetylase inhibitor, in human leukemic U937 cells.

  2007cited by this paper
• Presentation of childhood CNS tumours: a systematic review and meta-analysis.

  2007cited by this paper
• Histone Deacetylase Inhibitor–Mediated Radiosensitization of Human Cancer Cells: Class Differences and the Potential Influence of p53

  2006cited by this paper
• Trichostatin A induces apoptosis in lung cancer cells via simultaneous activation of the death receptor-mediated and mitochondrial pathway

  2006cited by this paper
• Aberrant expression of histone deacetylase 6 in oral squamous cell carcinoma.

  2006cited by this paper
• Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer

  2006cited by this paper
• Histone Deacetylase 3 (HDAC3) and Other Class I HDACs Regulate Colon Cell Maturation and p21 Expression and Are Deregulated in Human Colon Cancer*

  2006cited by this paper
• Valproic acid induces growth arrest, apoptosis, and senescence in medulloblastomas by increasing histone hyperacetylation and regulating expression of p21Cip1, CDK4, and CMYC

  2005cited by this paper
• Enhancement of in vitro and in vivo tumor cell radiosensitivity by valproic acid

  2005cited by this paper
• Histone deacetylase inhibitors induced caspase-independent apoptosis in human pancreatic adenocarcinoma cell lines

  2005cited by this paper
• Efflux of Depsipeptide FK228 (FR901228, NSC-630176) Is Mediated by P-Glycoprotein and Multidrug Resistance-Associated Protein 1

  2005cited by this paper
• Telomere maintenance in childhood primitive neuroectodermal brain tumors.

  2004cited by this paper
• DNA methylation as an epigenetic regulator of neural 5‐lipoxygenase expression: evidence in human NT2 and NT2‐N cells

  2004cited by this paper
• T-cell lymphoma as a model for the use of histone deacetylase inhibitors in cancer therapy: impact of depsipeptide on molecular markers, therapeutic targets, and mechanisms of resistance.

  2004cited by this paper
• On the road to immortality: hTERT upregulation in cancer cells

  2004cited by this paper
• Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis.

  2004cited by this paper
• Molecular sequelae of histone deacetylase inhibition in human malignant B cells.

  2003cited by this paper
• Sp1 and Sp3 Recruit Histone Deacetylase to Repress Transcription of Human Telomerase Reverse Transcriptase (hTERT) Promoter in Normal Human Somatic Cells*

  2002cited by this paper
• Apoptosis A Link between Cancer Genetics and Chemotherapy

  2002cited by this paper
• Histone-deacetylase inhibitors: novel drugs for the treatment of cancer

  2002cited by this paper
• Histone deacetylase inhibitors: a new class of potential therapeutic agents for cancer treatment.

  2002cited by this paper
• Histone deacetylase inhibitors suppress telomerase reverse transcriptase mrna expression in prostate cancer cells

  2002cited by this paper
• Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells

  2001cited by this paper
• Inhibitors of histone deacetylase are potentially effective anticancer agents.

  2001cited by this paper
• The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species

  2001cited by this paper
• Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT).

  2000cited by this paper
• Effect of Pneumolysin on Rat Brain Ciliary Function: Comparison of Brain Slices with Cultured Ependymal Cells

  2000cited by this paper
• Histone Deacetylation Is Involved in the Transcriptional Repression of hTERT in Normal Human Cells*

  2000cited by this paper
• Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells.

  1999cited by this paper
• Direct activation of TERT transcription by c-MYC

  1999cited by this paper
• In vivo and in vitro analyses of Myc for differential promoter activities of the human telomerase (hTERT) gene in normal and tumor cells.

  1999cited by this paper
• Proteasome Inhibitors Induce p53/p21-Independent Apoptosis in Human Glioma Cells

  1999cited by this paper
• Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene.

  1999cited by this paper
• p53- and p21-independent apoptosis of squamous cell carcinoma cells induced by 5-fluorouracil and radiation.

  1998cited by this paper
• Telomerase activity and alterations in telomere length in human brain tumors.

  1998cited by this paper
• Population based survival rates for childhood cancer in Britain, 1980-91

  1994cited by this paper
• Multipotent neural cell lines can engraft and participate in development of mouse cerebellum.

  1992cited by this paper

• Telomerase Regulation: A Role for Epigenetics

  2021cites this paper
• Molecular Stratification of Childhood Ependymomas as a Basis for Personalized Diagnostics and Treatment

  2021cites this paper
• Childhood Malignant Brain Tumors: Balancing the Bench and Bedside

  2021cites this paper
• Identification of key methylation differentially expressed genes in posterior fossa ependymoma based on epigenomic and transcriptome analysis

  2021cites this paper
• Therapeutic strategies for targeting telomerase in cancer

  2020cites this paper
• Limitations of current in vitro models for testing the clinical potential of epigenetic inhibitors for treatment of pediatric ependymoma

  2018cites this paper
• Epigenetic perturbation driving asleep telomerase reverse transcriptase: Possible therapeutic avenues in carcinoma

  2017cites this paper
• A novel histone deacetylase inhibitor, CKD5, has potent anti-cancer effects in glioblastoma

  2016cites this paper
• Human telomerase inhibitors from microbial source

  2015cites this paper
• The Simultaneous Effect of Valproic Acid and Gamma Radiation on Telomerase Activity and Bax and Bcl-2 Protein Levels in MCF-7 Breast Cancer Cell Line

  2015cites this paper
• Human telomerase inhibitors from microbial source

  2015cites this paper
• The correlation between telomerase activity and Bax/Bcl-2 ratio in valproic acid-treated MCF-7 breast cancer cell line

  2015cites this paper
• Screening and functional analysis of glioma‑related genes induced by candoxin.

  2014cites this paper
• Brain Tumor Genomics: Sequencing to Clinical Utility

  2014cites this paper
• RHPS4 G-Quadruplex Ligand Induces Anti-Proliferative Effects in Brain Tumor Cells

  2014cites this paper
• Ependymoma in children: molecular considerations and therapeutic insights

  2013cites this paper
• Adjuvant Chemotherapy for Brain Tumors Delivered via a Novel Intra-Cavity Moldable Polymer Matrix

  2013cites this paper
• Telomeres and Brain Tumors

  2013cites this paper
• Targeting of histone deacetylases in brain tumors.

  2013cites this paper
• Emerging Insights into the Ependymoma Epigenome

  2013cites this paper
• Tumor Prognostic Factors and the Challenge of Developing Predictive Factors

  2013cites this paper
• Telomerase as a Prognostic Marker and Therapeutic Target in Paediatric Ependymoma

  2013cites this paper
• Recapitulation of Tumor Heterogeneity and Molecular Signatures in a 3D Brain Cancer Model with Decreased Sensitivity to Histone Deacetylase Inhibition

  2012cites this paper
• Synergistic/additive interaction of valproic acid with bortezomib on proliferation and apoptosis of acute myeloid leukemia cells

  2012cites this paper
• Nestin Expression Identifies Ependymoma Patients with Poor Outcome

  2012cites this paper
• A novel human high-risk ependymoma stem cell model reveals the differentiation-inducing potential of the histone deacetylase inhibitor Vorinostat

  2011cites this paper
• Histone deacetylase inhibition as an anticancer telomerase‐targeting strategy

  2011influential citation
• Cellular Immortality in Brain Tumors: An Overview

  2011cites this paper
• Pediatric ependymomas: will molecular biology change patient management?

  2011cites this paper
• Potential Clinical Role of Telomere Length in Human Glioblastoma

  2011cites this paper
• Epigenetics, Nervous System Tumors, and Cancer Stem Cells

  2011cites this paper
• r a c t i c e

  2010cites this paper
• Iranian Journal of Basic Medical Sciences the Correlation between Telomerase Activity and Bax/bcl‐2 Ratio Blockinin Blockinvalproic Blockinacid‐treated Blockinmcf‐7 Blockinbreast Blockincancer Blockincell Blockinline

  year unknowncites this paper